Published October 23, 2025 | Version v1
Journal article Open

The Pharmacology of NSAIDs

Authors/Creators

  • 1. ROR icon Osh State University

Contributors

Supervisor:

  • 1. ROR icon Osh State University

Description

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are one of the most widely used classes of medications globally.1 They are a cornerstone of treatment for pain, fever, and inflammation.2 This article provides a detailed overview of their pharmacology, including their mechanism of action, classification, pharmacokinetics, and the critical balance between their therapeutic effects and significant adverse effects.

 

Files

Files (23.3 kB)

Name Size Download all
md5:df7c1f256a6f0e9434bd58db7d715771
23.3 kB Download

Additional details

Dates

Created
2025-10-23
B

References

  • 1. Brunton, L. L., Knollmann, B. C., & Hilal-Dandan, R. (Eds.). (2022). Goodman & Gilman's: The Pharmacological Basis of Therapeutics (14th ed.). McGraw-Hill Medical.
  • 2. Ghlichloo, I., & Gerriets, V. (2024). Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. o Available from: https://www.ncbi.nlm.nih.gov/books/NBK547742/
  • 3. Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020). Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochemical Pharmacology, 180, 114147.
  • 4. DynaMed. (2024). Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Overview. EBSCO Information Services.
  • 5. Arfè, A., Scotti, L., Varas-Lorenzo, C., Nicotra, F., Zambon, A., Koll-Marseille, A., ... & Corrao, G. (2016). Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. The BMJ, 354, i4857.
  • 6. Verbeeck, R. K., Blackburn, J. L., & Loewen, G. R. (1983). Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clinical Pharmacokinetics, 8(4), 297-331.
  • 7. Davies, N. M. (1998). Clinical pharmacokinetics of ibuprofen: the first 30 years. Clinical Pharmacokinetics, 34(2), 101-154.